|
Aksenov M.Y., Alsenova M.V., Butterfield D.A., Geddes J.W., Markesbery W.R.（2001）Protein oxidation in the brain in Alzheimer’s disease. Neuroscience 103:373-383
Allen J.W., Eldadah B.A., Faden A.I.（1999）Beta-amyloid-induced apoptosis of cerebellar granule cells and cortical neurons: exacerbation by selective inhibition of group I metabotropic glutamate receptors. Neuropharmacology 38:1243-1252
Arends M.J., Morris R.G., Wyllie A.H.（1990）Apoptosis. The role of endonucleases. American Journal of Pathology 136:593-608
Arispe N., Pollard H.B., Rojas E.（1993）Giant multilevel cation channels formed by Alzheimer’s disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proceedings of the National Academy of Sciences of the United States of America 90:10573-10577
Arispe N., Pollard H.B., Rojas E.（1994）The ability of amyloid beta-protein
[AβP-(1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America 747:256-266
Ba F., Pang P.K.T., Benishin C.G.（2003）The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. Journal of Neuroscience Methods 123:11-22
Ba F., Pang P.K.T., Benishin C.G.（2004）The role of Ca2+ channel modulation in the neuroprotective actions of estrogen in β-amyloid protein and MPTP cytotoxic models.
Neurochemistry International 45:31-38
Behl C., Davis J., Colle G.M., Schubert D.（1992）Vitamin E protects nerve from amyloid β protein toxicity. Biochemical and Biophysical Research Communications 186:944-950
Behl C., Davis J.B., Klier F.G., Schubert D.（1994a） Amyloid beta peptide induces necrosis rather than apoptosis. Brain Research 645:253-264
Behl C., Davis J.B., Lesley R., Schubert D.（1994b）Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827
Biedler J.L., Helson L., Spengler B.A.（1973）Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Research 33:2643-2652
Bennett M.R., Huxlin K.R.（1996） Neuronal cell death in mammalian nervous system: The calmortin hypothesis. General Pharmacology 27(3):407-419
Blanc E.M., Toborek M., Mark R.J., Hennig B., Mattson M.P.（1997）Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. Journal of neurochemistry 68:1870-1881
Bonventre J.V.（1990）Calcium in renal cells. Modulation of calcium-dependent activation of phospholipase A2. Environmental Health Perspectives 84:155-162
Brawn K., Fridovich I.（1981）DNA strand scission by enzymically generated oxygen radicals. Archives of Biochemistry and Biophysics 206:414-419
Bredesen D.E.（1995）Neural apoptosis. Annals of Neurology 38:839-851
Bruce A.J., Malfroy B., Baudry M.（1996）β-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proceedings of the National Academy of Sciences of the United States of America 93:2312-2316
Butterfielf D.A., Hensley K., Harris M., Mattson M.P., Carney J.（1994）β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer’s disease. Biochemical and Biophysical Research Communications 200:710-715
Buja L.M., Eigenbrodt M.L., Eigenbrodt E.H.（1993）Apoptosis and Necrosis: basic types and mechanisms of cell death. Archives of Pathology and Laboratory Medicine 117:1208-1214
Carafoli E.（1991）Calcium pump of the plasma membrane. Physiological Reviews 71:129-153
Cassarino D.S., Fall C.P., Swerdlow R.H., Smith T.S., Halvorsen E.M., Miller S.W., Parks J.P., Parks J.P., Parker Jr W.D., Bennett Jr J.P.（1997）Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson’s disease. Biochimica et Biophysica Acta 1362:77-86
Cassarino D.S., Halvorsen E.M., Swerdlow R.H., Abramova N.N., Parker Jr. W.D., Sturgill T.M., Bennett Jr. J.P.（2000）Interaction among mitochondria, mitogen-activated protein kinase, and nuclear factor-kappaB in cellular models of Parkinson’s disease. Journal of Neurochemistry 74:1384-1392
Chen F., Sun S., Kuhn D.C., Lu Y., Gaydos L.J., Shi X., Demers L.M.（1997）Tetrandrine inhibits signal-induced NF-κB activation in rat alveolar macrophages. Biochemical and Biophysical Research Communication 231:99-102
Chen K.C., Blalock E.M., Thibault O., Kaminker P., Landfield P.W.（2000）Expression of α1D subunit mRNA is correlated with L-type Ca2+ channel activity in single neurons of hippocampal ‘zipper’ slices. PANS:Pest articles & news summaries 97(8):4357-4362
Chen T.S., Koutsilieri E., Rausch W.D.（1995）MPP+ selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57/B16 mice. Journal of Neural Transmission General Section 100:153-163
Chiba K., Trevor A.J., Castagnoli Jr N.（1985）Active uptake of MPP＋, a metabolite of MPTP, by brain synaptosomes. Biochemical and Biophysical Research Communications 128:1228-1232
Chin H.（1998）Molecular biology of neuronal voltage-gated calcium channels. Experimental and Molecular Medicine 30(3):123-130
Collins F., Schmidt M.F., Guthrie P.B., Kater S.B.（1991）Sustained increase in intracellular calcium promotes neuronal survival. Journal of Neuroscience 11:2582-2587
Cotman C.W.（1997）The beta-amyloid peptide, peptide self-assembly, and the emergence of biological activities, a new principle in peptide function and the induction of neuropathology. Annals of the New York Academy of Sciences 814:1-16
Dawson T.M., Dawson V.L.（2003）Molecular pathways of neurodegeneration in Parkinson’s disease. Science 302:819-822
Dong Y., Yang M.M., Kwan C.Y.（1997）In vitro inhibition of proliferation of HL-60 cells by tetrandrine and corious versicolor peptide derived by Chinese medical herbs. Life Science 60:PL135-140
Drouet B., Pincon-Raymond M., Chambaz J., Pillot T.（2000）Molecular basis of Alzheimer’s disease. Cellular and Molecular Life Sciences 57:705-715
Duan W., Zhang Z., Gash D.M., Mattson M.P.（1999）Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson’s disease. Annals of Neurology 46:587-597
Eberhardt O. and Schulz J.B.（2003）Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson’s disease. Toxicology Letters 139:135-151
Ekinci F.J., Malik K.U., Shea T.B.（1999）Activation of the L voltage-sensitive calcium channel by mitogen-activated protein（MAP）kinase following exposure of neuronal cells to β-amyloid. The Journal of Biological Chemistry 274(42):30322-30327
Fall C.P., Bennett J.P.（1999）Characterization and time course of MPP+ induced apoptosis in human SH-SY5Y neyroblastoma cells. Journal of Neuroscience Research 55:620-628
Frankfurt O.S., Krishan A.（2001）Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin. The Journal of Histochemistry ＆ Cytochemistry 49(3):369-378
Frei B., Richter C.（1986）MPP+ together with 6-hydroxydopamine of dopamines stimulates Ca2+ release from mitochondria. FEBS Letters 198:99-102
Gao Y., Chang M.Y., Mao H.Y., Chen D.H.（1965）Treatment of hypertension（270 cases）and hypertensive crisis with tetrandrine. Chinese Journal of Internation Medicine 13:504-507
Gill D.L., Gosh T.K., Mullaney J.M.（1989）Calcium signaling mechanisms in endoplasmic reticulum activated by inositol-1,4,5 triphosphate and GTP. Cell Calcium 10:363-374
Gomez C., Reiriz J., Pique M., Gill J., Ferrer I., Ambrosio S.（2001）Low concentration of 1-methyl-4-phenylpyridinium ion induce caspase-mediate apoptosis in human SH-SY5Y neuroblastoma cells. Journal of Neuroscience Research 63:421-428
Goodman Y. and Mattson M.P.（1994）Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid-β-peptide-induced oxidative injury. Experimental Neurology 128:1-12
Goodman Y., Steiner M.R., Steiner S.M., Mattson M.P.（1994）Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Research 654:171-176
Greenamyre J.T., MacKenzie G., Peng T.I., Stephans S.E.（1999）Mitochondrial dysfunction in Parkinson’s disease. Biochem Soc Symp 66:85-97
Gschwind M., Huber G.（1995）Apoptotic cell death induced by beta-amyloid 1-42 peptide is cell type dependent. Journal of Neurochemistry 65:292-300
Gunter T.E., Pfeiffer D.R.（1990）Mechanisms by which mitochondria transport calcium. American Journal of Physiology 258:C755-C786
Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D.J.（1992）Nature 359:149-163
Haass C., Strooper B.D.（1999）The presenilins in Alzheimer’s disease-proteolysis holds the key. Science 286:916-919
Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A. Butterfield D.A.（1994）A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 91:3270-3274
Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory A., Wong J., Takenouchi T., Hashimoto M., Masliah E.（2000）α-synuclein promotes mitochondrial deficit and oxdative stress. American Journal of Pathology 157:401-410
Huang Y.T., Hong C.Y.（1998）Tetrandrine. Cardiovascular Drug Reviews 16:1-15
Johnson E.M., Koike T., Franklin J.（1992）A ”calcium set-point hypothesis” of neuronal dependence on neurotrophic factor. Experimental Neurology 115:163-166
Kass G.E., Wright J.M., Nicotera P., Orrenius S.（1988）The mechanism of MPTP toxicity: role of intracellular calcium. Archives of Biochemistry and Biophysics 260:789-797
Kawahara M., Kuroda Y.（2001）Intracellular calcium changes in neuronal cells induced by Alzheimer’s beta-amyloid protein are blocked by estradiol and cholesterol. Cellular and Molecular Neurobiology 21:1-13
Kerr J.F.R., Wyllie A.H., Currie A.R.（1972）Apoptosis: a biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 26:239-257
Kitamura Y., Kosaka T., Kakimura J., Matsuoka Y., Kohno Y., Nomura Y., Taniguchi T.（1998）Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells. The American Society for Pharmacology and Experimental Therapeutics 54:1046-1054
Koike T., Martin D.P., Johnson E.M.（1989）Role of Ca2＋ channels in the ability of membrane depolarization to prevent neuronal cell death induced by trophic factor deprivation: evidence that levels of internal Ca2＋ determine nerve growth factor dependence of sympathetic ganglion cells. Proceedings of the National Academy of Sciences of the United States of America 86:6421-6425
Kowall N.W., Beal F.M., Busciglio J., Duffy L.K., Yankner B.A.（1991）An in vivo model for neurodegenerative effects of β amyloid and protection by substance P. Proceedings of the National Academy of Sciences of the United States of America 88:7247-7251
Kupsch A., Gerlach M., Pupeter S.C.（1995）Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice. Neuroreport 6:621-625
Kupsch A., Sautter J., Schwarz J. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurotoxicity in non-human primates is antagonized by pretreatment at the nigral, but not at the striatal level. Brain Research 741:185-196
Kwan C.Y.（1994）Plant-derived drugs acting on cellular Ca2＋ mobilization in vascular smooth muscle: tetramethylpyrazine and tetrandrine. Stem Cells 12:64-67
Lapetina E.G., Crouch M.F.（1989）The relationship between phospholipases A2 and C in signal transduction. Annals of the New York Academy of Sciences 559:153-157
Lev N., Melamed E., Offen D.（2003）Apoptosis and Parkinson’s disease. Progress in Neuro-Psychopharmacology ＆ Biological Psychiatry 27:245-250
Lin L.L., Wartman M., Lin A.Y., Knopf J.L., Seth A., Davis R.J.（1993）cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278
Liu Q.Y., Karpinski E., Rao M.R., Pang P.K.（1991）Tetrandrine：a novel calcium channel antagonist inhibits type 1 calcium channels in neuroblastoma cells. Neuropharmacology 30:1325-1331.
Lin Q.Y., Karpinski E., Pang P.K.（1992）Tetrandrine inhibits both T and L calcium channel currents in ventricular cells. Journal of Cardiovascular Pharmacology 20:513-519
Luo Y., Hawver D.B., Iwasaki K., Sunderland T., Roth G.S., Wolozin B.（1997）Physiological levels of β-amyloid peptide stimulate protein kinase C in PC12 cells. Brain Research 769:287-295
Magyar K., Haberle D.（1999）Neuroprotective and neuronal rescue effects of selegiline: review. Neurobiology 7:175-190
Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E.（1992）β-amyloid peptides destabilized calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience 12:376-389
Mattson M.P., Tomaselli K.J., Rydel R.E.（1993b）Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptides are attenuated by basic FGF. Brain Research 621:35-49
Mattson M.P., LaFeria F.M., Chan S.L., Leissring M.A., Shepel P.N., Geiger J.D.（2000）Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends in Neuroscience 23:222-229
Monte D.A.D., Lavasani M., Manning-Bog A.B.（2002）Environmental factors in Parkinson’s disease. NeuroToxicology 23:487-502
Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R.J., Shirasaki Y., AD Greenberg M.E.（2001）β-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. Journal of Neuroscience 21:7551-7560
Mosmann T.（1983）Rapid colorimetric assay for cellular growth and survival:
Application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65:55-63
Mullan N., Crawford F.（1993）Genetic and molecular advances in Alzheimer’s disease. Trends in Neurosciences 16:398-403
Nicklas W.J., Vyas I., Heikkila R.E.（1985）Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridinium, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Science 36:2503-2508
Offen D., Elkon H., Melamed E.（2000）Apoptosis as a general cell death pathway in neurodegenerative diseases. Journal of Neural Transmission 58:153-166
Pang L., Hoult J.R.（1997）Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid, accompanied by an overproduction of prostaglandins. Biochemical Pharmacology 53:773-782
Paschen W., Frandsen A.（2001）Endoplasmic reticulum dysfunction- a common denominator for cell injury in acute and degenerative disease of brain？Journal of Neurochemistry 79:719-725
Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W.（1991）In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Research 563:279-282
Porter N.M., Thibault O., Thibault V., Chen K.C., Landfield P.W.（1997）Calcium channel density and hippocampal cell death with age in long-term culture. Journal of Neuroscience 17:5629-5639
Przedborski S., Jackson-Lewis V. （1998）Mechanisms of MPTP toxicity. Movement Disorder 13:35-38
Reeve H.L., Vaughan P.F., Peers C.（1995）Enhancement of Ca2+ channel currents in human neuroblastoma（SH-SY5Y）cells by phorbol esters without activation of protein kinase C. Pflugers Archiv : European Journal of Physiology 429:729-737
Reist R.H., Dey R.D., Durham J.P., Rojanasakul Y., Castranova V.（1993）Inhibition of proliferation activity of pulmonary fibroblasts by tetrandrine. Toxicology ＆ Applied Pharmacology 122:70-76
Salamino F., DeTullio R., Mengotti P., Viotti P.L., Melloni E., Pontremoli S.（1993）Site-directed activation of calpain is promoted by a membrane-associated natural activator protein. The Biochemical Journal 290:191-197
Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D.（1992）Nature 359:315-320
Shen Y.C., Chen C.F., Sung Y.J.（1999a）Tetrandrine ameliorates ischemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation. British Journal of Pharmacology 128:1593-1601
Shen Y.C., Chen C.F., Wang S.Y., Sung Y.J.（1999b）Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil mac-1 up-regulation and adhesion by tetrandrine. Molecular Pharmacology 55:186-193
Shen Y.C., Chou C.J., Chiou W.F., Chen C.F.（2001）Anti-inflammatory effects of the partially purified extract of radix stephaniae tetrandrae：comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Molecular Pharmacology 60:1083-1090
Sherer T.B., Betarbet R., Stout A.K., Lund S., Baptista M., Panov A.V., Cookson M.R., Greenamyre J.T.（2002）An in vitro model of Parkinson’s disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxdative damage. The Journal of Neuroscience 22(16):7006-7015
Shimoke K., Chiba H.（2001）Nerve growth factor prevents MPTP-induced cell death via Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutic application for Parkinson’s disease. Journal of Neuroscience Research 63:402-409
Stadman E.R.（1993）Oxidation of free amino acid and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annual Review of Biochemistry 62:797-821
Takemura H., Imoto K., Ohshika H., Kwan C.Y.（1996）Tetrandrine as a calcium antagonist. Clinical and Experimental Pharmacology and Physiology 23:751-753
Tran M.H., Yamada K., Olariu A., Mizuno M., Ren X.H., Nabeshima T.（2001）Amyloid β-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB Journal 15:1407-1409
Trump B.F., Berezesky I.K.（1995）Calcium-mediated cell injury and cell death. FASEB Journal 9:219-228
Ueda K., Fukui Y., Kageyama H.（1994）Amyloid β protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid β protein. Brain Research
639:240-244
Ueda K., Shinohara S., Yagami T., Asakura K., Kawasaki K.（1997）Amyloid β protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals. Journal of Neurochemistry 68:265-271
Veng L.M., Mesches M.H., Browning M.D.（2003）Age-related working memory impairment is correlated with increases in the L-type calcium channel protein α1D（Cav1.3）in area CA1 of the hippocampus and both are ameliorated by chronic nimodipine treatment. Molecular Brain Research 110:193-202
Votyakova T.V., Reynolds I.J.（2001）ΔΨm-dependent and –independent production of reactive oxygen species by rat brain mitochondria. Journal of neurochemistry 79:266-277
Weiss J.H., Pike C.J., Cotman C.W.（1994）Ca2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. Journal of Neurochemistry 62:372-375
Wang G., Lemos J.R.（1995）Tetrandrine:a new ligand to block voltage-depend Ca2＋and Ca2＋activated K＋channels. Life Science 56:295-306
Wang H.L., Kilfeather S.A., Martin G.R., Page C.P.（2000）Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells. Pulmonary Pharmacology ＆ Therapeutics 13:53-60
Wang K.K.W., Yuen P.W.（1994）Calpain inhibition: an overview of its therapeutic potential. Trends in Pharmacology 15:412-419
Xia X.G., Harding T., Weller M., Bieneman A., Uney J.B., Schulz J.B.（2001）Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America 98:10433-10438
Yankner B.A., Duffy L.K., Kirschner D.A.（1990）Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279-282
Yu X.C., Wu S., Wang G.Y., Shan J., Wong T.M., Chen C.F., Pang K.T.（2001）Cardiac infarct, arrhythmias, coronary arterial flow and heart rate in the isolated perfused rat heart. Life Science 68:2863-2872
|